Variation in Prosthetic Joint Infection and treatment strategies during 4.5 years of follow-up after primary joint arthroplasty using administrative data of 41397 patients across Australian, European and United States hospitals

Abstract Background To identify best practices and quality improvement initiatives, we aimed to assess whether the incidence of Periprosthetic Joint Infection (PJI) and treatment strategies differed across patients treated in Australian, European and United States (US) hospitals. Methods Routinely c...

Full description

Bibliographic Details
Main Authors: Perla J. Marang-van de Mheen, Ellie Bragan Turner, Susan Liew, Nora Mutalima, Ton Tran, Sten Rasmussen, Rob G. H. H. Nelissen, Andrew Gordon
Format: Article
Language:English
Published: BMC 2017-05-01
Series:BMC Musculoskeletal Disorders
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12891-017-1569-2
_version_ 1830297643590352896
author Perla J. Marang-van de Mheen
Ellie Bragan Turner
Susan Liew
Nora Mutalima
Ton Tran
Sten Rasmussen
Rob G. H. H. Nelissen
Andrew Gordon
author_facet Perla J. Marang-van de Mheen
Ellie Bragan Turner
Susan Liew
Nora Mutalima
Ton Tran
Sten Rasmussen
Rob G. H. H. Nelissen
Andrew Gordon
author_sort Perla J. Marang-van de Mheen
collection DOAJ
description Abstract Background To identify best practices and quality improvement initiatives, we aimed to assess whether the incidence of Periprosthetic Joint Infection (PJI) and treatment strategies differed across patients treated in Australian, European and United States (US) hospitals. Methods Routinely collected administrative data for 41397 patients undergoing a primary total hip or knee arthroplasty between July 2007-December 2010 across 22 hospitals were included. Patients were followed for 2 years looking for PJI occurrence, defined as early (within 4 weeks) and late PJI, and surgical treatment during 2.5 years after PJI diagnosis. Logistic and Poisson regression models were used to test for differences in PJI occurrence and treatment strategies across the three geographical regions, adjusted for age, sex, joint and Elixhauser comorbidity groups. Results PJI occurrence varied from 1.4% in European to 1.7% in Australian patients, which were significantly higher than US patients after adjustment for patient characteristics (OR 1.24 [1.01–1.52] and 1.40 [1.03–1.91] respectively). Early PJIs varied between 0.3% in European to 0.6% in Australian patients, but adjusted rates were similar. Revision following PJI was significantly lower in Australian than in US patients (OR 0.46 [0.25–0.86]) as were the total number of revisions (RR 0.51 [0.36–0.71]) and number of surgical procedures (RR 0.60 [0.44–0.81]) used to treat PJI. Conclusion The overall PJI rate was significantly higher in Australian patients, but fewer procedures were needed to treat these PJIs. Future research should reveal whether this reflects PJIs caught earlier or less severe when diagnosed, and whether this is associated with the longer length of stay after primary arthroplasty in Australian hospitals.
first_indexed 2024-12-19T07:38:24Z
format Article
id doaj.art-772e21f275774622966bbfd24e87a0f5
institution Directory Open Access Journal
issn 1471-2474
language English
last_indexed 2024-12-19T07:38:24Z
publishDate 2017-05-01
publisher BMC
record_format Article
series BMC Musculoskeletal Disorders
spelling doaj.art-772e21f275774622966bbfd24e87a0f52022-12-21T20:30:32ZengBMCBMC Musculoskeletal Disorders1471-24742017-05-011811810.1186/s12891-017-1569-2Variation in Prosthetic Joint Infection and treatment strategies during 4.5 years of follow-up after primary joint arthroplasty using administrative data of 41397 patients across Australian, European and United States hospitalsPerla J. Marang-van de Mheen0Ellie Bragan Turner1Susan Liew2Nora Mutalima3Ton Tran4Sten Rasmussen5Rob G. H. H. Nelissen6Andrew Gordon7Department of Medical Decision Making, Leiden University Medical CenterDr Foster LtdDepartment of Orthopaedic Surgery, Alfred HospitalDepartment of Orthopaedic Surgery, Monash HealthDepartment of Orthopaedic Surgery, Monash HealthOrthopaedic Surgery Research Unit, Aalborg University HospitalDepartment of Orthopaedic Surgery, Leiden University Medical CenterDepartment of Orthopaedic Surgery, Sheffield Teaching Hospitals NHS trustAbstract Background To identify best practices and quality improvement initiatives, we aimed to assess whether the incidence of Periprosthetic Joint Infection (PJI) and treatment strategies differed across patients treated in Australian, European and United States (US) hospitals. Methods Routinely collected administrative data for 41397 patients undergoing a primary total hip or knee arthroplasty between July 2007-December 2010 across 22 hospitals were included. Patients were followed for 2 years looking for PJI occurrence, defined as early (within 4 weeks) and late PJI, and surgical treatment during 2.5 years after PJI diagnosis. Logistic and Poisson regression models were used to test for differences in PJI occurrence and treatment strategies across the three geographical regions, adjusted for age, sex, joint and Elixhauser comorbidity groups. Results PJI occurrence varied from 1.4% in European to 1.7% in Australian patients, which were significantly higher than US patients after adjustment for patient characteristics (OR 1.24 [1.01–1.52] and 1.40 [1.03–1.91] respectively). Early PJIs varied between 0.3% in European to 0.6% in Australian patients, but adjusted rates were similar. Revision following PJI was significantly lower in Australian than in US patients (OR 0.46 [0.25–0.86]) as were the total number of revisions (RR 0.51 [0.36–0.71]) and number of surgical procedures (RR 0.60 [0.44–0.81]) used to treat PJI. Conclusion The overall PJI rate was significantly higher in Australian patients, but fewer procedures were needed to treat these PJIs. Future research should reveal whether this reflects PJIs caught earlier or less severe when diagnosed, and whether this is associated with the longer length of stay after primary arthroplasty in Australian hospitals.http://link.springer.com/article/10.1186/s12891-017-1569-2Periprosthetic Joint InfectionInternational variationTotal joint replacementTreatment strategies
spellingShingle Perla J. Marang-van de Mheen
Ellie Bragan Turner
Susan Liew
Nora Mutalima
Ton Tran
Sten Rasmussen
Rob G. H. H. Nelissen
Andrew Gordon
Variation in Prosthetic Joint Infection and treatment strategies during 4.5 years of follow-up after primary joint arthroplasty using administrative data of 41397 patients across Australian, European and United States hospitals
BMC Musculoskeletal Disorders
Periprosthetic Joint Infection
International variation
Total joint replacement
Treatment strategies
title Variation in Prosthetic Joint Infection and treatment strategies during 4.5 years of follow-up after primary joint arthroplasty using administrative data of 41397 patients across Australian, European and United States hospitals
title_full Variation in Prosthetic Joint Infection and treatment strategies during 4.5 years of follow-up after primary joint arthroplasty using administrative data of 41397 patients across Australian, European and United States hospitals
title_fullStr Variation in Prosthetic Joint Infection and treatment strategies during 4.5 years of follow-up after primary joint arthroplasty using administrative data of 41397 patients across Australian, European and United States hospitals
title_full_unstemmed Variation in Prosthetic Joint Infection and treatment strategies during 4.5 years of follow-up after primary joint arthroplasty using administrative data of 41397 patients across Australian, European and United States hospitals
title_short Variation in Prosthetic Joint Infection and treatment strategies during 4.5 years of follow-up after primary joint arthroplasty using administrative data of 41397 patients across Australian, European and United States hospitals
title_sort variation in prosthetic joint infection and treatment strategies during 4 5 years of follow up after primary joint arthroplasty using administrative data of 41397 patients across australian european and united states hospitals
topic Periprosthetic Joint Infection
International variation
Total joint replacement
Treatment strategies
url http://link.springer.com/article/10.1186/s12891-017-1569-2
work_keys_str_mv AT perlajmarangvandemheen variationinprostheticjointinfectionandtreatmentstrategiesduring45yearsoffollowupafterprimaryjointarthroplastyusingadministrativedataof41397patientsacrossaustralianeuropeanandunitedstateshospitals
AT elliebraganturner variationinprostheticjointinfectionandtreatmentstrategiesduring45yearsoffollowupafterprimaryjointarthroplastyusingadministrativedataof41397patientsacrossaustralianeuropeanandunitedstateshospitals
AT susanliew variationinprostheticjointinfectionandtreatmentstrategiesduring45yearsoffollowupafterprimaryjointarthroplastyusingadministrativedataof41397patientsacrossaustralianeuropeanandunitedstateshospitals
AT noramutalima variationinprostheticjointinfectionandtreatmentstrategiesduring45yearsoffollowupafterprimaryjointarthroplastyusingadministrativedataof41397patientsacrossaustralianeuropeanandunitedstateshospitals
AT tontran variationinprostheticjointinfectionandtreatmentstrategiesduring45yearsoffollowupafterprimaryjointarthroplastyusingadministrativedataof41397patientsacrossaustralianeuropeanandunitedstateshospitals
AT stenrasmussen variationinprostheticjointinfectionandtreatmentstrategiesduring45yearsoffollowupafterprimaryjointarthroplastyusingadministrativedataof41397patientsacrossaustralianeuropeanandunitedstateshospitals
AT robghhnelissen variationinprostheticjointinfectionandtreatmentstrategiesduring45yearsoffollowupafterprimaryjointarthroplastyusingadministrativedataof41397patientsacrossaustralianeuropeanandunitedstateshospitals
AT andrewgordon variationinprostheticjointinfectionandtreatmentstrategiesduring45yearsoffollowupafterprimaryjointarthroplastyusingadministrativedataof41397patientsacrossaustralianeuropeanandunitedstateshospitals